# HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma

> **NCT02487849** · PHASE2 · WITHDRAWN · sponsor: **Krankenhaus Barmherzige Schwestern Linz**

## Conditions studied

- Epithelial Ovarian Cancer
- Peritoneal Cancer
- Fallopian Tube Cancer

## Interventions

- **PROCEDURE:** HIPEC
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02487849
- **Lead sponsor:** Krankenhaus Barmherzige Schwestern Linz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** actually limited personnel ressources
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02487849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02487849, "HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02487849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*